Skip to main content

Table 2 Bivariate correlations between accelerometer assessed sedentary behaviour patterns, light physical activity and MVPA with 10-year CVD risk, individual CVD risk factors and functional disability

From: Sedentary behaviour is associated with increased long-term cardiovascular risk in patients with rheumatoid arthritis independently of moderate-to-vigorous physical activity

 

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

1

Age

2

Sedentary time (min/day)

.29*

                   

3

bLPA (min/day)

−.22

−.78**

                  

4

bMVPA (min/day)

−.22

−.37**

.35**

                 

5

Number of Sbreaks (number/day)

−.12

−.26*

.61**

.03

                

6

Number of Sbouts (number/day)

.31*

.81*

−.79**

−.26**

−.67**

               

7

Average time per Sbout (min)

.07

.34**

−.50**

−.09

−.56**

.45**

              

8

Q-risk

.76**

.37**

−.40**

−.12

−.21

.38**

.20

             

9

bCRP (mg/L)

.18

.05

−.20

−.24

−.20

.15

.09

.28*

            

10

bESR (mm/h)

.12

.20

−.23

−.21

−.09

.21

−.01

.17

.57**

           

11

Fibrinogen (g/L)

.25

.20

−.27*

−.23

−.19

.31*

.03

.29*

.69**

.71**

          

12

Total cholesterol (mmol/L)

.18

.17

−.10

−.18

.04

.03

.11

.09

.10

.14

− .03

         

13

bHDL-C (mmol/L)

.05

−.11

.27*

.02

.30*

−.25†

−.17

−.33*

−.20

−.10

−.24

.29*

        

14

bLDL-C (mmol/L)

.15

.22

−.19

−.14

−.13

.15

.19

.19

.22

.19

.06

.86**

−.09

       

15

bTriglycerides (mmol/L)

.10

.13

−.19

−.17

−.02

.08

.17

.22

−.00

.14

.11

.33*

−.24b

.13

      

16

Syst-BP (mm HG)

.53**

.19

−.09

−.04

.05

.17

.04

.52**

.16

.19

.17

.11

.28*

−.11

.22

     

17

Diast-BP (mm HG)

.37*

.08

.15

.02

.11

.13

.01

.30*

−.05

−.03

−.01

.12

.23

−.07

.22

.71**

    

18

bPlasma insulin (mmol/L)

−.08

.05

−.11

−.21

−.08

.13

−.08

.16

.28*

.35*

.37*

−.03

−.47**

.08

.37**

.10

.14

   

19

bPlasma glucose (mmol/L)

.02

.04

−.04

.06

.05

.01

.11

.12

.06

.13

.10

.07

−.30*

.12

.27*

.10

.19

.51**

  

20

bHOMA status

−.08

.06

−.09

−.17

−.02

.09

−.01

.16

.23

.30*

.31*

−.04

−.47**

.05

.35**

.06

.12

.94**

.74**

 

21

 HAQ

.09

.13

−.23

−.27*

−.16

.17

.06

.13

.18

.27**

.23

−.04

−.03

.03

−.11

.07

.02

.26**

− .04

.18

  1. Note: * p < .05, ** p < .01, † p = .05, a p = .06. b Indicates non-normally distributed data that has been log transformed for inclusion parametric statistical tests
  2. LPA light physical activity, MVPA moderate-to-vigorous physical activity, Sbreaks sedentary breaks, Sbouts sedentary bouts, CVD cardiovascular disease, HOMA homeostatic model assessment, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, CRP C-reactive protein, ESR erythrocyte sedimentation rate, Qrisk Q-risk score, HAQ Health Assessment Questionnaire